Literature DB >> 29196274

Neuromuscular diseases: Diagnosis and management.

P Mary1, L Servais2, R Vialle2.   

Abstract

Neuromuscular diseases (NMDs) affect the peripheral nervous system, which includes the motor neurons and sensory neurons; the muscle itself; or the neuromuscular junction. Thus, the term NMDs encompasses a vast array of different syndromes. Some of these syndromes are of direct relevance to paediatric orthopaedic surgeons, either because the presenting manifestation is a functional sign (e.g., toe-walking) or deformity (e.g., pes cavus or scoliosis) suggesting a need for orthopaedic attention or because orthopaedic abnormalities requiring treatment develop during the course of a known NMD. The main NMDs relevant to the orthopaedic surgeon are infantile spinal muscular atrophy (a motor neuron disease), peripheral neuropathies (chiefly, Charcot-Marie-Tooth disease), congenital muscular dystrophies, progressive muscular dystrophies, and Steinert myotonic dystrophy (or myotonic dystrophy type 1). Muscle weakness is a symptom shared by all these conditions. The paediatric orthopaedic surgeon must be familiar, not only with the musculoskeletal system, but also with many other domains (particularly respiratory and cardiac function and nutrition) that may interfere with the treatment and require preoperative management. Good knowledge of the natural history of each NMD is essential to ensure optimal timing of the therapeutic interventions, which must be performed under the best possible conditions in these usually frail patients. Timing is particularly crucial for the treatment of spinal deformities due to paraspinal muscle hypotonia during growth: depending on the disease and natural history, the treatment may involve non-operative methods or growing rods, followed by spinal fusion. A multidisciplinary approach is always required. Finally, the survival gains achieved in recent years increasingly require attention to preparing for adult life, to orthopaedic problems requiring treatment before the patient leaves the paediatric environment, and to the transition towards the adult healthcare system.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Muscular dystrophy; Neuromuscular diseases; Neuromuscular scoliosis; Spinal muscular atrophy

Mesh:

Year:  2017        PMID: 29196274     DOI: 10.1016/j.otsr.2017.04.019

Source DB:  PubMed          Journal:  Orthop Traumatol Surg Res        ISSN: 1877-0568            Impact factor:   2.256


  11 in total

Review 1.  Development of a straight vertebrate body axis.

Authors:  Michel Bagnat; Ryan S Gray
Journal:  Development       Date:  2020-10-06       Impact factor: 6.868

2.  ActRIIB:ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders.

Authors:  Jia Li; Maureen Fredericks; Marishka Cannell; Kathryn Wang; Dianne Sako; Michelle C Maguire; Rosa Grenha; Katia Liharska; Lavanya Krishnan; Troy Bloom; Elitza P Belcheva; Pedro A Martinez; Roselyne Castonguay; Sarah Keates; Mark J Alexander; Hyunwoo Choi; Asya V Grinberg; R Scott Pearsall; Paul Oh; Ravindra Kumar; Rajasekhar Nvs Suragani
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

Review 3.  Congenital or Early Developing Neuromuscular Diseases Affecting Feeding, Swallowing and Speech - A Review of the Literature from January 1998 to August 2021.

Authors:  Lotta Sjögreen; Lisa Bengtsson
Journal:  J Neuromuscul Dis       Date:  2022

4.  The Dog Model in the Spotlight: Legacy of a Trustful Cooperation.

Authors:  Inès Barthélémy; Christophe Hitte; Laurent Tiret
Journal:  J Neuromuscul Dis       Date:  2019

5.  Experience in neuromuscular diseases in children and adolescents and their comorbidities in a tertiary hospital.

Authors:  J A Gascón-Navarro; J Torres-Borrego; M J De La Torre-Aguilar; J A Fernández-Ramos; J L Pérez-Navero
Journal:  Ital J Pediatr       Date:  2021-11-16       Impact factor: 2.638

6.  Surface Electromyography Thresholds as a Measure for Performance Fatigability During Incremental Cycling in Patients With Neuromuscular Disorders.

Authors:  Nicoline B M Voet; Christiaan G J Saris; Dick H J Thijssen; Vincent Bastiaans; David E Sluijs; Mariska M H P Janssen
Journal:  Front Physiol       Date:  2022-03-17       Impact factor: 4.566

Review 7.  An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases.

Authors:  Federica Marra; Paola Lunetti; Rosita Curcio; Francesco Massimo Lasorsa; Loredana Capobianco; Vito Porcelli; Vincenza Dolce; Giuseppe Fiermonte; Pasquale Scarcia
Journal:  Biomolecules       Date:  2021-11-04

8.  Case Report: Prenatal Diagnosis of Nemaline Myopathy.

Authors:  Dongmei Liu; Jiali Yu; Xin Wang; Yang Yang; Li Yu; Shi Zeng; Ming Zhang; Ganqiong Xu
Journal:  Front Pediatr       Date:  2022-07-19       Impact factor: 3.569

9.  Cross-sectorial collaboration on policy-driven rehabilitation care models for persons with neuromuscular diseases: reflections and behavior of community-based health professionals.

Authors:  Charlotte Handberg; Ulla Werlauff
Journal:  BMC Health Serv Res       Date:  2022-09-17       Impact factor: 2.908

10.  Perioperative Optimization of Patients With Neuromuscular Disorders Undergoing Scoliosis Corrective Surgery: A Multidisciplinary Team Approach.

Authors:  Fady Sedra; Roozbeh Shafafy; Ahmed-Ramadan Sadek; Syed Aftab; Alexander Montgomery; Ramesh Nadarajah
Journal:  Global Spine J       Date:  2020-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.